Prashanth Mayur

Clinical Associate Professor Prashanth Mayur is affiliated with the University of Sydney's Westmead Clinical School, part of the Sydney Medical School within the Faculty of Medicine and Health. His clinical specialty is Psychiatry, with a strong focus on electroconvulsive therapy (ECT) research and its application in severe psychiatric conditions such as schizophrenia, treatment-resistant depression, and bipolar disorder. He has contributed extensively to understanding ECT parameters, including ultrabrief pulse efficacy, high-dose protocols, and adjunct therapies like transcranial direct current stimulation.

His research spans over a decade, emphasizing the optimization of ECT delivery, neuroimaging correlates of treatment response, and clinical outcomes in pandemic contexts. Key contributions include studies on habenula connectivity in depression, ECT safety during the COVID-19 pandemic, and innovative case reports addressing clozapine-resistant symptoms and dissociative disorders.

Mayur's publications highlight his expertise in translating neurobiological insights into clinical practice, with a particular interest in advancing ECT protocols to improve treatment outcomes for complex psychiatric cases. His work frequently employs rigorous methodologies, including randomized controlled trials and single-case analyses.